Karyn Dyehouse works in the field of Hematology. She graduated from University Hospital - University of Cincinnati College of Medicine. She received 1 awards: "Meaningful Use Stage 1 Certification". Doctor Karyn M. Dyehouse, MD is a published physician. She published 1 publication, including: 'A Phase II trial of Denileukin Diftitox in patients with previously treated advanced non-small cell lung cancer.' She accepts Medicare payments and is listed with Medicare.gov.
NPI NUMBER | 1649297094 | |
NPPES Provider LastName | DYEHOUSE | |
NPPES Provider FirstName | KARYN | |
NPPES Provider ZIPCode | 452302163 | |
NPPES Provider State | OH | |
Specialty Description | Hematology/Oncology | |
Total Claim Count | 1696.0 | |
Distinct Opioid Count | 7.0 | |
Opioid Claim Count | 239.0 | |
Percent Opioid Claims | 14.09 |
National Provider Identifier [NPI] | 1649297094 |
Last Name Of The Provider | DYEHOUSE |
First Name Of The Provider | KARYN |
View All |
![]() |
Dr. Edward J. Crane, MD
![]() |
![]() |
Dr. David L. Kirlin, MD
![]() |
![]() |
Dr. Cynthia C. Chua, MD
![]() |
![]() |
Dr. David M. Waterhouse, MD
![]() ![]() |
![]() |
Dr. Rebecca G. Bechhold, MD
![]() ![]() |
![]() |
Dr. Mary E. McCullough, MD |